HM
BMY.RT

Harvest Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Harvest Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-132,000
Closed -$91K – 87
2020
Q4 		$91K Sell
132,000
-88,200
-40% -$188K 0.07% 40
2020
Q3 		$495K Buy
220,200
+70,000
+47% +$200K 0.54% 30
2020
Q2 		$538K Buy
150,200
+35,000
+30% +$126K 1.92% 16
2020
Q1 		$438K Sell
115,200
-3,147
-3% -$10.4K 0.71% 27
2019
Q4 		$356K Buy
+118,347
New +$308K 0.71% 33

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Harvest Management's BMY.RT Position: Q1 2021 in Review

Harvest Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 132,000 shares — an estimated $91K sold.

Harvest Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $538K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Harvest Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Harvest Management sold 132,000 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $91K.
  • Harvest Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Harvest Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $538K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Harvest Management's 13F filing for Q1 2021, filed 4 May 2021.